A Baltimore biotechnology company has raised $4 million, to help bring its therapeutic treatment targeting rare genetic diseases closer to market.
{iframe}https://www.bizjournals.com/baltimore/news/2018/07/09/baltimore-based-biotech-dedicated-to-developing.html{/iframe}